Alerta De Seguridad para CALEX Cap Device

Según Department of Health, este evento ( alerta de seguridad ) involucró a un dispositivo médico en Hong Kong que fue producido por BÜHLMANN Laboratories AG.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • Fecha
    2017-03-20
  • Fecha de publicación del evento
    2017-03-20
  • País del evento
  • Fuente del evento
    DH
  • URL de la fuente del evento
  • Notas / Alertas
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notas adicionales en la data
    Medical Device Safety Alert
  • Causa
    Medical device safety alert: bühlmann laboratories ag calex cap device bühlmann laboratories ag has issued a medical device safety alert concerning its calex cap device [catalogue number: b-calex-c50, b-calex-c200, b-calex-c500]. according to the manufacturer, a mean positive bias of 15.6 % has been confirmed for results obtained with stool extraction using the original calex cap device in comparison to results obtained with the reference manual weighing and extraction method – 1:50 dilution. given the overall analytical and clinical performance of fecal calprotectin assays and the general imprecision level of stool extraction methods, the above mean bias of 15.6 % is considered to have limited impact on result interpretation. the positive bias may, in few cases, lead or have led to the interpretation of calprotectin levels as elevated (> 200 μg/g), requiring further investigative and curative procedures. with stool specimen preparation using the reference manual extraction procedure, they would be determined as having a low inflammatory response thus repeating the measurement and performing further investigations would be recommended. in few cases patients may be or may have been assigned as having a low inflammatory response (> 50μg/g), although, with stool specimen preparation using the reference manual extraction procedure, they would be determined as having normal calprotectin values. affected users are advised to the take the following actions:- when reviewing current calprotectin results obtained for stool specimens extracted with the original calex cap device (calex lots without “n”), consider the positive bias described above. a fast transition to the calex cap “n” device with high method agreement with the manual weighing and extraction – 1:50 dilution method is recommended. according to the local supplier, the affected products are distributed in hong kong. if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 20 march 2017.

Device

  • Modelo / Serial
  • Descripción del producto
    Medical Device Safety Alert: BÜHLMANN Laboratories AG CALEX Cap Device
  • Manufacturer

Manufacturer